Studies with enaminones: Synthesis and chemical reactivity of 2-(4-dimethylamino-2-oxobut-3-enyl)-isoindole-1,3-dione and of 4-(4-dimethylamino-2-oxobut-3-enyloxy)-2H-phthalazin-1-one

Journal of Heterocyclic Chemistry

Volumn 41, Issue 3, 2004, Pages 381-385

  Al Mousawi, Saleh ^a   John, Elizabeth ^a   Al Kandery, Najat ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

2 (4 DIMETHYLAMINO 2 OXOBUT 3 ENYL)ISOINDOLE 1,3 DIONE; 4 (4 DIMETHYLAMINO 2 OXOBUT 3 ENYLOXY) 2H PHTHALAZIN 1 ONE; 4 ACETONYLOXYPHTHALAZIN 1 ONE; ACETONYLPHTHALIMIDE; DIMETHYLFORMAMIDE DIMETHYLACETAL; ENAMINE; ENAMINONE DERIVATIVE; HETEROCYCLIC COMPOUND; N,N DIMETHYLACETAMIDE; PHTHALIMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ALKYLATION; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL REACTION; CHEMICAL STRUCTURE; NUCLEAR OVERHAUSER EFFECT; POLYMERIZATION; STRUCTURE ANALYSIS; SYNTHESIS;

EID: 3042720303     PISSN: 0022152X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jhet.5570410312     Document Type: Article

References (25)

1. R. Troschutz and A. Karger, J. Heterocyclic Chem., 34, 1147 (1997).
2. R. M. Robertson and D. Robertson, The Pharmacological Basis of Therapeutics, Goodman and Gilman's p.759, 9th edition. A. G. Gilman, consulting ed's, Mcgraw-Hill Health, professions division. New York (1996).
3. A. E. Farah, A. A. Alousi, Life Science, 22, 1139 (1978).
4. A. A. Alousi, J. M. Canter, J. M. Montenaro, D. J. Fort and R. A. Ferrari, J. Cardiovascular pharmacology, 5, 792 (1983).
5. J. Lambrecht, W. Ardanuy, H. C. Baumart, X. Bo, C. V. H. Hoyle, P. Nickel, O. Pfaff, V. Ralevic, U. Windschief, A. U. Ziganshin, R. Ziyal, E. Mutschler and G. Bumstock, in Perspectives in Receptor Research, D. Giardina, S. Piergentili, M. Pigini (eds), p.33, Elsevier, Amsterdam (1996).
6. S. M. Agamy, M. M. Abdel Khalik, M. H. Mohammed and M. H. Elnagdi, Z Naturjorsch, 56b, 1074 (2001).
7. S. M. Al-Mousawi, K. S. George and M. H. Elnagdi, Pharmazie, 54, 971 (1999).
8. M. M. Abdel Khalik, and M. H. Elnagdi, Synthetic Communications, 32, 159 (2002).
9. F. Al-Omran, A. A. El-Khair and M. H. Elnagdi, J. Chem. Res. (s) 798 (1998).
10. B. Al-Saleh, M. M. Abdel Khalik, A. M. Eltoukhy and M. H. Elnagdi, J. Heterocyclic Chem., 39, 1035 (2002).
11. F. Al-Omran, N. Al-Awadi, A. A. El-Khair and M. H. Elnagdi, Org. Prep. And Proced. Int., 29, 285 (1997).
12. B. Al-Saleh, M. M. Abdel Khalik, E. Darwich, O. A. M. Salah and M. H. Elnagdi, Heteroatom Chem., 13, 141 (2002).
13. B. Al-Saleh, M. M. Abdel Khalik, A. El-Apasery and M. H. Elnagdi, J. Heterocyclic Chem., 40, 171 (2003).
14. F. Al-Omran, J. Heterocyclic Chem., 37, 1219 (2000).
15. F. Al-Omran, Y. A. Osama and A. A. El-Khair, J. Heterocyclic Chem., 37, 1617 (2000).
16. B. Al-Saleh, N. Al-Awadi, H. Al-Kandari, M. M. Abdel Khalik and M. H. Elnagdi, J. Chem. Res. (s), 16, Ibid(M) 201 (2000).
17. B. Al-Saleh, N. Al-Awadi, H. Al-Kandari, M. M. Abdel Khalik and M. H. Elnagdi, J. Chem. Res. (s), 16, Ibid(M) 201 (2000).
18. S. M. Al-Mousawi, M. M. Abdel Khalik, S. El-Sherbiny, E. John and M. H. Elnagdi, J. Heterocyclic Chem., 38, 949 (2001).
19. P. G. Ruminski, US, 5,681,820 (16 May 1995); Chem. Abstr., 127, 331754z (1997).
20. E. Bosies, R. Endele and W. Pahike, US, 4,826,858 (2 May 1989);Chem. Abstr., 111, 225311n (1989).
21. D. Baucke, M. Helmut, S. Wemer, W. Homberger, G. Backfisch, J. Delzer, DE Appl. 10,006,799, (15 Feb 2000); Chem. Abstr., 133, 296664v (2000).
22. A. El-Enzy, B. Al-Saleh and M. H. Elnagdi, J. Chem. Res. (s), 4; Ibid (M) 110 (1997).
23. A. El-Enzy, B. Al-Saleh and M. H. Elnagdi, J. Chem. Res. (s), 4; Ibid (M) 110 (1997).
24. B. Al-Saleh, M. M. Abdel Khalik, A. El-Enzy and M. H. Elnagdi, J. Chem. Res. (s), 648; Ibid (M) 2801 (1999).
25. B. Al-Saleh, M. M. Abdel Khalik, A. El-Enzy and M. H. Elnagdi, J. Chem. Res. (s), 648; Ibid (M) 2801 (1999).